Company: CMND
Filing Date: 2025-12-05
Form Type: F-1/A
Source: 0001213900-25-118772
Chunk: 219

Company: Clearmind Medicine Inc.
Filing Date: 2025-12-05
Form: F-1/A
Chunk 219
---
 dissolution of the corporation, are generally            
 required to be approved by the holders of a majority of the outstanding stock entitled to vote on the matter, unless the certificate of           
 incorporation requires a higher percentage.                                                                                                       
 However, under the DGCL, mergers in which less than 20% of a corporation’s                                                                        
 stock outstanding immediately prior to the effective date of the merger is issued generally do not require stockholder approval. In certain       
 situations, the approval of a business combination may require approval by a certain number of the holders of a class or series of shares.        
 In addition, Section 251(h) of the DGCL provides that stockholders of a constituent corporation need not vote to approve a merger if:             
 (i) the merger agreement permits or requires the merger to be effected under Section 251(h) and provides that the merger shall be effected        
 as soon as practicable following the tender offer or exchange offer, (ii) a corporation consummates a tender or exchange offer for any            
 and all of the outstanding stock of such constituent corporation that would otherwise be entitled to vote to approve the merger, (iii)            
 following the consummation of the offer, the stock accepted for purchase or exchanges plus the stock owned by the consummating corporation        
 equals at least the percentage of stock that would be required to adopt the agreement of merger under the DGCL, (iv) the corporation consummating 
 the offer merges with or into such constituent corporation and (v) each outstanding share of each class or series of stock of the constituent     
 corporation that was the subject of and not irrevocably accepted for purchase or exchange in the offer is to be converted in the merger           
 into, or the right to receive, the same consideration to be paid for the shares of such class or series of stock of the constituent corporation   
 irrevocably purchased or exchanged in such offer.                                                                                                 
 The DGCL does not contain a procedure comparable to a plan of arrangement                                                                         
 under BCBCA.                                                                                                                                      |     | Under the BCBCA and our articles, certain extraordinary company alterations,                                                                     
 such as changes to authorized share structure, continuances, into or out of province, certain amalgamations, sales, leases or other dispositions 
 of all or substantially all of the undertaking of a company (other than in the ordinary course of business) liquidations, dissolutions,          
 and certain arrangements are required to be approved by ordinary or special resolution as applicable.                                            
 An ordinary resolution is a resolution (i) passed